Head-to-head comparison
AVARA Rx vs Get Thin MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
AVARA Rx is a nationwide DTC telehealth platform offering compounded semaglutide and tirzepatide plus brand-name Wegovy, Zepbound, and Foundayo consultations, alongside HRT, TRT, and longevity add-ons.
From $229/mo (lowest dose rung) sema · From $279/mo (lowest dose rung) tirz · Verified June 2026
Marked down on: Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
Desk Score
Get Thin MD is a nationwide async telehealth platform offering compounded semaglutide and tirzepatide injections plus brand-name Ozempic and Zepbound where appropriate.
$199/mo sema · $299/mo tirz · Verified June 2026
Marked down on: Compounded medications aren't FDA-approved and lack the review of brand-name GLP-1s
Get Thin MD takes this head-to-head with the higher Desk Score, 82/100 (B−) against 68/100 (C) for AVARA Rx. AVARA Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
AVARA Rx
68/100
C
Get Thin MD
82/100
B−
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | AVARA Rx | Get Thin MD |
|---|---|---|
| Semaglutide | From $229/molowest dose rung$229/mo (starting dose, compounded) | $199/mo$199/mo (compounded) |
| Tirzepatide | From $279/molowest dose rung$279/mo (starting dose, compounded) | $299/mo$299/mo (compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | 50-state compounded GLP-1 with named pharmacy and clinical network. | Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. |
| Desk Score | 68/100C | 82/100B− |
The verdict
Desk pick — Get Thin MDGet Thin MD takes this head-to-head with the higher Desk Score, 82/100 (B−) against 68/100 (C) for AVARA Rx. AVARA Rx still holds its ground where its strengths line up with yours.
Choose AVARA Rx if…
50-state compounded GLP-1 with named pharmacy and clinical network.
From $229/mo (lowest dose rung) sema · From $279/mo (lowest dose rung) tirz · All 50 states
Choose Get Thin MD if…
Lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available.
$199/mo sema · $299/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: AVARA Rx · Get Thin MD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- AVARA Rx vs CoreAge Rx
- CoreAge Rx vs Get Thin MD
- AVARA Rx vs Eden
- Eden vs Get Thin MD
- AVARA Rx vs Pallas Health
- Get Thin MD vs Pallas Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.